Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.48 |
| ▸ | FABP3 | P05413 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6909100 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL6913554 | 0.97 | L3MBTL1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL6907913 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL6916441 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL6916435 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL11466346 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| Bromide SCHEMBL6113408 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL6113042 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| SCHEMBL11079483 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD | |
| Iodide SCHEMBL6113169 | 0.97 | TDP1 (0.59) | TDP1L3MBTL1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1809 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| CN-114901653-B | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2024-11-22 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117801970-A | Hansenula polymorpha (Hanseniaspora uvarum) strain 181 with grape juice, application, product and method thereof | 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) | 2024-04-02 | — | — | CN | claimed |
| CN-114901273-A | Pharmaceutical compositions of CASR modulators and methods and uses thereof | 鲁平有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114901653-A | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2022-08-12 | — | — | CN | claimed |
| CN-114605306-B | Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof | 南京师范大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114790136-A | Preparation method and application of active trivalent organic chromium compound | 中国石油天然气股份有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-111620832-B | Multi-substituted oxazoline compound and preparation method thereof | 南京工业大学 | 2022-07-05 | — | — | CN | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| US-20010007038-A1 | Catalyst and method for amide formation | SCOTT WILLIAM LEONARD (US) | 2001-07-05 | — | — | US | claimed |
| EP-1045835-A1 | CATALYST AND METHOD FOR AMIDE FORMATION | ELI LILLY AND COMPANY (US) | 2000-10-25 | — | — | EP | claimed |
| US-6121471-A | Catalyst and method for amide formation | ELI LILLY AND COMPANY (US) | 2000-09-19 | — | — | US | claimed |
| WO-1999032444-A1 | CATALYST AND METHOD FOR AMIDE FORMATION | ELI LILLY AND COMPANY (US) | 1999-07-01 | — | — | WO | claimed |
| CN-1180739-A | Health-care wine and preparation method thereof | XU BAOSHI (CN) | 1998-05-06 | — | — | CN | claimed |
| EP-0507576-A1 | Polypropylene-based resin compositions | TOSOH CORPORATION (JP) | 1992-10-07 | — | — | EP | claimed |
| EP-0187462-B1 | SUPPORTED OLEFIN POLYMERIZATION CATALYST | AMOCO CORPORATION (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0169650-A2 | Process for preparing aromatic urethanes from nitroaromatic compounds | Montedison S.p.A. (IT) | 1986-01-29 | — | — | EP | claimed |
| US-4154921-A | REDUCE FORMATION OF SCALE BY ADDITION OF A HINDERED BENZOIC ACID INCLUDING 2,6-DICHLORO-, 2,6-DIMETHYL-, AND 2,4,6-TRIMETHYL-/; | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010007038-A1 | Catalyst and method for amide formation | HAT1, MOGAT2, H1-2 | TDP1 2295/4885L3MBTL1 2546/4885KDM4E 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.